Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.430
0.00 (0.00%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Organogenesis Holdings Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Organogenesis Holdings stock has a target of 3.00, which predicts an increase of 23.46% from the current stock price of 2.43.
Analyst Consensus: Hold
* Price targets were last updated on May 28, 2026.
Analyst Ratings
The average analyst rating for Organogenesis Holdings stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jun 23, 2026 |
| Truist Financial | Truist Financial | Hold Initiates $3 | Hold | Initiates | $3 | +23.46% | May 28, 2026 |
Financial Forecast
Revenue This Year
282.86M
from 564.17M
Decreased by -49.86%
Revenue Next Year
337.59M
from 282.86M
Increased by 19.35%
EPS This Year
-0.82
from 0.42
EPS Next Year
-0.28
from -0.82
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 284.0M | 343.7M | |
| Avg | 282.9M | 337.6M | |
| Low | 281.7M | 331.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -49.7% | 21.5% | |
| Avg | -49.9% | 19.3% | |
| Low | -50.1% | 17.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.82 | -0.28 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.